Spots Global Cancer Trial Database for oral leukoplakia
Every month we try and update this database with for oral leukoplakia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Intra and Extra Oral Inspection of Oral Mucosa | NCT04079491 | Oral Lichen Pla... Oral Leukoplaki... Erythroplakia | questionnaire s... | - | Dalarna County Council, Sweden | |
| Intralesional 5-fluorouracil Injection for the Treatment of Oral Leukoplakia | NCT05505539 | Oral Leukoplaki... | 5-fluorouracil | 18 Years - | University of California, San Francisco | |
| Prediction of Malignant Transformation of Oral Leukoplakia Using a MAGE-A-based Immunoscore | NCT03975322 | Oral Leukoplaki... Oral Leukoplaki... Oral Leukoplaki... Oral Lichen Pla... | 18 Years - 80 Years | University of Erlangen-Nürnberg Medical School | ||
| Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia | NCT05237960 | Erythroplakia Oral Leukoplaki... | Biopsy Biospecimen Col... Extended Releas... Placebo Adminis... | 21 Years - | University of Arizona | |
| A Phase II Trial to Assess the Effects of Green Tea in Oral Leukoplakia | NCT00176566 | Oral Leukoplaki... | Lozenge Intake | 18 Years - | Rutgers, The State University of New Jersey | |
| Comparison or Rose Bengal and Toluidine Blue Staining for Lesion Detection Efficacy | NCT03031899 | Oral Leukoplaki... Oral Lichen Pla... Premalignant Le... | Biopsy Rose Bengal toluidine blue | 18 Years - | The Oxford Dental College, Hospital and Research Center, Bangalore, India | |
| Oral Cancer Screening and Education in Hong Kong | NCT04487938 | Oral Cancer Oral Leukoplaki... Oral Submucous ... Proliferative V... Oral Erythropla... Erosive Lichen ... | No intervention... | 45 Years - | The University of Hong Kong | |
| Candida Associated Cytokines in Oral Leukoplakia | NCT04712929 | Oral Leukoplaki... | Fluconazole | 18 Years - 100 Years | All India Institute of Medical Sciences, New Delhi | |
| Identification of Oral Lesions Through an Autofluorescence System | NCT05942794 | Oral Leukoplaki... Autofluorescenc... Secondary Preve... Keratosis Oral Lichen Pla... Oral Cancer Oral Disease | Screening exami... | 18 Years - 70 Years | Federico II University | |
| Diagnostic Accuracy of Salivary DNA Integrity Index in Oral Malignant and Premalignant Lesions | NCT03682562 | Oral Cancer Oral Lichen Pla... Oral Leukoplaki... | DNA Integrity I... | 20 Years - 70 Years | Cairo University | |
| Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia | NCT05727761 | Oral Leukoplaki... | pioglitazone-me... | 18 Years - | University of Minnesota | |
| Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Oral Leukoplakia | NCT00571558 | Oral Leukoplaki... | aminolevulinic ... photodynamic th... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia | NCT00330382 | Lip and Oral Ca... Oral Leukoplaki... Oropharyngeal C... Tongue Cancer | Bowman-Birk inh... placebo laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Evaluation of Effect of Topical Melatonin in Treatment of Oral Leukoplakia | NCT04251845 | Oral Leukoplaki... | topical melaton... PLACEBO | 18 Years - | Postgraduate Institute of Dental Sciences Rohtak | |
| Candida Associated Cytokines in Oral Leukoplakia | NCT04712929 | Oral Leukoplaki... | Fluconazole | 18 Years - 100 Years | All India Institute of Medical Sciences, New Delhi | |
| Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia | NCT00101335 | Head and Neck C... Precancerous Co... | celecoxib | 18 Years - | Fox Chase Cancer Center | |
| Analyzing Handprint Patterns to Predict Oral Cancer Risks: A Comparative Study | NCT06256809 | Oral Leukoplaki... | - | King Khalid University | ||
| Least Invasive Nonlinear Light Microscopy | NCT00767442 | Oral Leukoplaki... Oral Cancer | 18 Years - 80 Years | National Taiwan University Hospital | ||
| Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion | NCT02581137 | Erythroplakia Hyperplasia Oral Cavity Car... Oral Leukoplaki... | Laboratory Biom... Metformin Hydro... | 18 Years - | National Cancer Institute (NCI) | |
| Oral Cancer Screening and Education in Hong Kong | NCT04487938 | Oral Cancer Oral Leukoplaki... Oral Submucous ... Proliferative V... Oral Erythropla... Erosive Lichen ... | No intervention... | 45 Years - | The University of Hong Kong | |
| Aspirin Mouthwash in Treating Patients With Oral Leukoplakia | NCT01238185 | Precancerous Co... | acetylsalicylic... gene expression... protein express... laboratory biom... questionnaire a... biopsy | - | National Cancer Institute (NCI) | |
| Candida Associated Cytokines in Oral Leukoplakia | NCT04712929 | Oral Leukoplaki... | Fluconazole | 18 Years - 100 Years | All India Institute of Medical Sciences, New Delhi | |
| Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia | NCT00155337 | Oral Leukoplaki... | photodynamic th... | 20 Years - 80 Years | National Taiwan University Hospital | |
| Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia | NCT00101335 | Head and Neck C... Precancerous Co... | celecoxib | 18 Years - | Fox Chase Cancer Center | |
| Pioglitazone for Oral Premalignant Lesions | NCT00951379 | Oral Leukoplaki... | Pioglitazone hy... placebo laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Oral Epithelial Dysplasia Informational Needs Questionnaire | NCT04153266 | Oral Epithelial... Precancerous Co... Precancerous Le... Oral Lichen Pla... Oral Leukoplaki... Oral Leukoplaki... Oral Leukoplaki... Oral Leukoplaki... Oral Erythropla... Chronic Hyperpl... Oral Submucous ... Oral Submucosal... Oral Disease Dental Diseases Dysplasia Information See... Patient Prefere... Information Nee... Health Behavior Quality of Life Preference, Pat... Patient Satisfa... Patient Engagem... Patient Partici... | No intervention... | 18 Years - | University College, London | |
| Intralesional 5-fluorouracil Injection for the Treatment of Oral Leukoplakia | NCT05505539 | Oral Leukoplaki... | 5-fluorouracil | 18 Years - | University of California, San Francisco | |
| Comparison or Rose Bengal and Toluidine Blue Staining for Lesion Detection Efficacy | NCT03031899 | Oral Leukoplaki... Oral Lichen Pla... Premalignant Le... | Biopsy Rose Bengal toluidine blue | 18 Years - | The Oxford Dental College, Hospital and Research Center, Bangalore, India | |
| Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia | NCT05727761 | Oral Leukoplaki... | pioglitazone-me... | 18 Years - | University of Minnesota | |
| Prediction of Malignant Transformation of Oral Leukoplakia Using a MAGE-A-based Immunoscore | NCT03975322 | Oral Leukoplaki... Oral Leukoplaki... Oral Leukoplaki... Oral Lichen Pla... | 18 Years - 80 Years | University of Erlangen-Nürnberg Medical School | ||
| Biomarkers for Oral Cancer | NCT00341497 | Lichen Planus Oral Leukoplaki... Mouth Neoplasms | 18 Years - 110 Years | National Institutes of Health Clinical Center (CC) | ||
| Diagnostic Accuracy of Salivary Gamma-synuclein in Oral Malignant and Premalignant Lesions | NCT04732741 | Oral Cancer Oral Lichen Pla... Oral Leukoplaki... Premalignant Le... | Salivary Gamma-... Incisional biop... Conventional vi... | 20 Years - 80 Years | Cairo University | |
| Rosiglitazone Maleate in Treating Patients With Oral Leukoplakia | NCT00369174 | Oral Leukoplaki... | rosiglitazone m... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Intralesional 5-fluorouracil Injection for the Treatment of Oral Leukoplakia | NCT05505539 | Oral Leukoplaki... | 5-fluorouracil | 18 Years - | University of California, San Francisco | |
| Pioglitazone for Oral Premalignant Lesions | NCT00951379 | Oral Leukoplaki... | Pioglitazone hy... placebo laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Photodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Oral Leukoplakia | NCT00571558 | Oral Leukoplaki... | aminolevulinic ... photodynamic th... laboratory biom... | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
